Xponance’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Xponance’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,300	Closed	-$222K	–	1065
2020 Q2	$222K	Buy	+2,300	New	+$192K	0.01%	934

Other funds holding MYOK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Xponance's MYOK Position: Q3 2020 in Review

Xponance sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2020, closing a stake of 2,300 shares — an estimated $222K sold.

Xponance first reported a position in MYOK in Q2 2020 and held it in 1 quarter. The position peaked at $222K in Q2 2020. 237 funds tracked by Wall St. Rank hold MYOK as of Q3 2020.

Xponance reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Xponance sold 2,300 MyoKardia, Inc. Common Stock shares in Q3 2020, an estimated $222K.
Xponance first reported a position in MyoKardia, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
Xponance's MyoKardia, Inc. Common Stock position peaked at $222K in Q2 2020.
237 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2020.

Based on Xponance's 13F filing for Q3 2020, filed 26 Oct 2020.